Imaging Glutamate Release From Alcohol
NCT04159688 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 8
Last updated 2024-10-09
Summary
The goal of this research project is to determine the sensitivity of PET radioligands specific for targets in the glutamate system to an alcohol challenge.
Conditions
- Alcohol Drinking
Interventions
- DRUG
-
Alcohol
Alcohol Challenge
Sponsors & Collaborators
-
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
collaborator NIH -
Yale University
lead OTHER
Principal Investigators
-
Ansel T Hillmer, Ph.D. · Yale University
Study Design
- Allocation
- NA
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 21 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-03-01
- Primary Completion
- 2022-06-30
- Completion
- 2022-06-30
Countries
- United States
Study Locations
More Related Trials
-
Biodistribution of [11C]Acetoacetate/[18F]Fluorodeoxyglucose in Subjects With Risk Factors for Alzheimer's Disease
NCT03130036 ·Status: COMPLETED ·Phase: NA
-
Use of [123I] AV39 and SPECT Imaging as a Marker of Protein Disposition in Subjects With Alzheimer Disease Compared to Healthy Subjects
NCT00439010 ·Status: COMPLETED ·Phase: PHASE1
-
MRS Probe Study of Alcohol
NCT01679444 ·Status: COMPLETED ·Phase: NA
-
PET Imaging of DHA Metabolism
NCT00074503 ·Status: COMPLETED
-
Kappa Opioid Receptor Imaging in Anorexia
NCT02240797 ·Status: TERMINATED
-
Evaluation of [18F] FMH3 and PET as a Marker of Histamine-3 Receptor Activity in Subjects With AD Compared w/ HC
NCT01268020 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
PET Changes in Alzheimer's Disease (AD)
NCT00094913 ·Status: UNKNOWN
-
Positron Emission Tomography (PET) to Study Brain Signaling
NCT00044200 ·Status: COMPLETED
-
Brain-imaging and Adolescent Neuroscience Consortium
NCT01511679 ·Status: WITHDRAWN
-
Peripheral Benzodiazepine Receptors (PBR28) Brain PET Imaging With Lipopolysaccharide Challenge for the Study of Microglia Function in Alzheimer's Disease
NCT04057807 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Verification of the Safety of Normal Food Before a Cerebral Arteriography
NCT04477031 ·Status: COMPLETED
-
Evaluation of [123I] AV83 and SPECT in Patients With Alzheimer Disease in Comparison to Healthy Controls
NCT00448799 ·Status: COMPLETED ·Phase: PHASE1
-
PET Scan of Brain Metabolism in Relation to Age and Disease
NCT00001972 ·Status: COMPLETED
-
Evaluation of [18F] PBR111 and PET as a Marker of Inflammation in Subjects With Neurological Conditions
NCT01209156 ·Status: COMPLETED ·Phase: PHASE1
-
Proof of Mechanism of a New Ketogenic Supplement Using Dual Tracer PET (Positron Emission Tomography)
NCT02551419 ·Status: COMPLETED ·Phase: NA
-
Evaluation of a Novel PET Radioligand to Image OGA
NCT03632226 ·Status: COMPLETED
-
Cue Induced Imaging in Nicotine Dependent Smokers
NCT00844701 ·Status: COMPLETED
-
Amyloid Imaging and Cognitive Impairment After Intracerebral Hemorrhage
NCT01619709 ·Status: COMPLETED ·Phase: NA
-
Brain Blood Flow Studies of Language and Memory
NCT00001288 ·Status: COMPLETED
-
PET Scan to Map the Areas of the Brain Involved in Planning
NCT00001363 ·Status: COMPLETED
-
PET Study of the Nicotinic System in Epilepsy
NCT03268369 ·Status: COMPLETED ·Phase: NA
-
Developing Advanced Neuroimaging for Clinical Evaluation of Autoimmune Encephalitis
NCT05280600 ·Status: RECRUITING
-
Imaging Inflammation With Alcohol Use Disorder: an [18F]NOS Study
NCT05885594 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Supplementing Neuro-Energy to Aid Cognition
NCT06767124 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Exploratory Positron Emission Tomography (PET) Study to Evaluate the Effects of ABT-614 on [11C]-(+)-PHNO Binding Potential to D3 Receptors in the Brain
NCT00788801 ·Status: COMPLETED ·Phase: PHASE1